Accera Pharma

Accera, a privately held biotechnology company, discovers and develops breakthroughs in treating central nervous systems disorders. Accera’s new and novel therapeutic approaches positively impact patients with neurodegenerative disorders, who are in need of effective, well-tolerated treatments, and their families. Through its proprietary scientific platform, Accera is developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells.